"Fibrosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.
| Descriptor ID |
D005355
|
| MeSH Number(s) |
C23.550.355
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fibrosis".
Below are MeSH descriptors whose meaning is more specific than "Fibrosis".
This graph shows the total number of publications written about "Fibrosis" by people in this website by year, and whether "Fibrosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1999 | 0 | 3 | 3 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 1 | 1 | 2 |
| 2003 | 2 | 1 | 3 |
| 2004 | 1 | 1 | 2 |
| 2005 | 1 | 4 | 5 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 5 | 5 |
| 2008 | 0 | 5 | 5 |
| 2009 | 0 | 6 | 6 |
| 2010 | 0 | 6 | 6 |
| 2011 | 1 | 4 | 5 |
| 2012 | 3 | 11 | 14 |
| 2013 | 1 | 7 | 8 |
| 2014 | 1 | 6 | 7 |
| 2015 | 2 | 8 | 10 |
| 2016 | 0 | 6 | 6 |
| 2017 | 0 | 14 | 14 |
| 2018 | 2 | 5 | 7 |
| 2019 | 2 | 4 | 6 |
| 2020 | 2 | 14 | 16 |
| 2021 | 4 | 8 | 12 |
| 2022 | 0 | 11 | 11 |
| 2023 | 0 | 6 | 6 |
| 2024 | 3 | 4 | 7 |
| 2025 | 0 | 3 | 3 |
| 2026 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fibrosis" by people in Profiles.
-
Differential Biventricular Strain Recovery With Selective Fibrosis Biomarker Regression After Sleeve Gastrectomy: A Prospective CMR Feature-Tracking Study. Obes Surg. 2026 Aug; 36(8):4368-4377.
-
Menin-dependent megakaryocyte proliferation and fibrosis in myeloproliferative neoplasms. Cancer Cell. 2026 Aug 10; 44(8):1639-1652.e6.
-
Transcription factor 21 deletion from podocyte precursors as a model for congenital nephrotic syndrome. Am J Physiol Renal Physiol. 2026 06 01; 330(6):F746-F760.
-
YAP-Induced Glycolysis Drives Fibroinflammation and Disrupts Fibroblast Fidelity. Circ Res. 2025 Dec 05; 137(12):1443-1458.
-
Inhibition of Talin2 dedifferentiates myofibroblasts and reverses lung and kidney fibrosis. Sci Rep. 2025 May 23; 15(1):18010.
-
Engineering IL-10 and rapamycin to bind collagen leads to improved anti fibrotic efficacy in lung and kidney fibrosis. Sci Rep. 2025 Apr 17; 15(1):13279.
-
Blocking antibodies against integrin-a3, -aM, and -aMß2 de-differentiate myofibroblasts, and improve lung fibrosis and kidney fibrosis. Sci Rep. 2024 09 16; 14(1):21623.
-
Metabolic control of collagen synthesis. Matrix Biol. 2024 11; 133:43-56.
-
Use of Atrial Fibrillation Electrograms and T1/T2 Magnetic Resonance Imaging to Define the Progressive Nature of Molecular and Structural Remodeling: A New Paradigm Underlying the Emergence of Persistent Atrial Fibrillation. J Am Heart Assoc. 2024 03 05; 13(5):e032514.
-
IL11-mediated stromal cell activation may not be the master regulator of pro-fibrotic signaling downstream of TGFß. Front Immunol. 2024; 15:1293883.